JP2023549265A5 - - Google Patents
Info
- Publication number
- JP2023549265A5 JP2023549265A5 JP2023528665A JP2023528665A JP2023549265A5 JP 2023549265 A5 JP2023549265 A5 JP 2023549265A5 JP 2023528665 A JP2023528665 A JP 2023528665A JP 2023528665 A JP2023528665 A JP 2023528665A JP 2023549265 A5 JP2023549265 A5 JP 2023549265A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- approximately
- formulation according
- lipids
- sodium chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063114478P | 2020-11-16 | 2020-11-16 | |
| US63/114,478 | 2020-11-16 | ||
| US202063115588P | 2020-11-18 | 2020-11-18 | |
| US63/115,588 | 2020-11-18 | ||
| PCT/EP2021/081674 WO2022101469A1 (en) | 2020-11-16 | 2021-11-15 | Compositions and methods for stabilization of lipid nanoparticle mrna vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549265A JP2023549265A (ja) | 2023-11-22 |
| JP2023549265A5 true JP2023549265A5 (https=) | 2026-04-27 |
Family
ID=78770624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528665A Pending JP2023549265A (ja) | 2020-11-16 | 2021-11-15 | 脂質ナノ粒子ｍＲＮＡワクチンの安定化のための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240041785A1 (https=) |
| EP (1) | EP4243789A1 (https=) |
| JP (1) | JP2023549265A (https=) |
| KR (1) | KR20230109689A (https=) |
| AU (1) | AU2021380033A1 (https=) |
| CA (1) | CA3198311A1 (https=) |
| IL (1) | IL302770A (https=) |
| MX (1) | MX2023005697A (https=) |
| WO (1) | WO2022101469A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA42543A (fr) | 2015-07-30 | 2018-06-06 | Modernatx Inc | Arn épitope peptidiques concatémériques |
| EP4011451A1 (en) | 2015-10-22 | 2022-06-15 | ModernaTX, Inc. | Metapneumovirus mrna vaccines |
| MA46766A (fr) | 2016-11-11 | 2019-09-18 | Modernatx Inc | Vaccin antigrippal |
| WO2018170245A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Broad spectrum influenza virus vaccine |
| US11905525B2 (en) | 2017-04-05 | 2024-02-20 | Modernatx, Inc. | Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins |
| EP3746090A4 (en) | 2018-01-29 | 2021-11-17 | ModernaTX, Inc. | RSV RNA Vaccines |
| IL297419B2 (en) | 2020-04-22 | 2025-02-01 | BioNTech SE | Coronavirus vaccine |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| WO2022232585A1 (en) * | 2021-04-29 | 2022-11-03 | Modernatx, Inc. | Lyophilization methods for preparing lipid formulated therapeutics |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| WO2024081639A1 (en) * | 2022-10-11 | 2024-04-18 | Seawolf Therapeutics, Inc. | Novel lipid nanoparticle compositions for the delivery of nucleic acids |
| WO2024089634A1 (en) * | 2022-10-27 | 2024-05-02 | Pfizer Inc. | Immunogenic compositions against influenza and rsv |
| IL320459A (en) * | 2022-10-27 | 2025-06-01 | Pfizer | Rna molecules encoding rsv-f and vaccines containing them |
| JP2026500218A (ja) * | 2022-12-11 | 2026-01-06 | ファイザー・インク | インフルエンザおよびｒｓｖに対する免疫原性組成物 |
| CN116139108B (zh) * | 2023-04-23 | 2023-08-01 | 威瑞生物科技(昆明)有限责任公司 | 一种脂质递送系统及其所构成的类病毒结构疫苗 |
| CN119101681A (zh) * | 2023-06-09 | 2024-12-10 | 仁景(苏州)生物科技有限公司 | 表达可调控的工程化rna分子 |
| WO2025038371A1 (en) * | 2023-08-11 | 2025-02-20 | Purdue Research Foundation | Salt-loaded solid lipid nanoparticles loaded with an active agent |
| WO2025077899A1 (zh) * | 2023-10-13 | 2025-04-17 | 北京先声祥瑞生物制品股份有限公司 | 一种核酸药物冻干制剂及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101766408B1 (ko) * | 2009-06-10 | 2017-08-10 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| WO2016005004A1 (en) | 2014-07-11 | 2016-01-14 | Biontech Rna Pharmaceuticals Gmbh | Stabilization of poly(a) sequence encoding dna sequences |
| HRP20230209T1 (hr) * | 2015-10-28 | 2023-04-14 | Acuitas Therapeutics Inc. | Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina |
| WO2017218704A1 (en) * | 2016-06-14 | 2017-12-21 | Modernatx, Inc. | Stabilized formulations of lipid nanoparticles |
| CA3040337A1 (en) * | 2016-10-26 | 2018-05-03 | Curevac Ag | Lipid nanoparticle mrna vaccines |
| US20220009878A1 (en) * | 2018-10-02 | 2022-01-13 | Intellia Therapeutics, Inc. | Ionizable amine lipids |
| JP2023511633A (ja) * | 2020-01-28 | 2023-03-20 | モデルナティエックス インコーポレイテッド | コロナウイルスｒｎａワクチン |
-
2021
- 2021-11-14 US US18/036,679 patent/US20240041785A1/en active Pending
- 2021-11-15 KR KR1020237020260A patent/KR20230109689A/ko active Pending
- 2021-11-15 IL IL302770A patent/IL302770A/en unknown
- 2021-11-15 CA CA3198311A patent/CA3198311A1/en active Pending
- 2021-11-15 EP EP21814751.0A patent/EP4243789A1/en active Pending
- 2021-11-15 AU AU2021380033A patent/AU2021380033A1/en active Pending
- 2021-11-15 JP JP2023528665A patent/JP2023549265A/ja active Pending
- 2021-11-15 WO PCT/EP2021/081674 patent/WO2022101469A1/en not_active Ceased
- 2021-11-15 MX MX2023005697A patent/MX2023005697A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023549265A5 (https=) | ||
| EP0879062B1 (en) | Nucleic acid delivery vehicle | |
| EP0729351B1 (en) | Vesicles with controlled release of actives | |
| US9655848B2 (en) | Liposomes for in-vivo delivery | |
| US7288266B2 (en) | Liposome complexes for increased systemic delivery | |
| US6413544B1 (en) | Liposome complexes for increased systemic delivery | |
| US6815432B2 (en) | Methods for encapsulating plasmids in lipid bilayers | |
| JP3676976B2 (ja) | 多胞状リポソームへの薬剤封入量の調節 | |
| AU2004212944B2 (en) | Lipophilic drug delivery vehicle and methods of use thereof | |
| US6770291B2 (en) | Liposome complexes for increased systemic delivery | |
| US20090041835A1 (en) | Method of inhibiting leakage of drug encapsulated in liposomes | |
| WO2007037444A1 (ja) | 目的物質を核内又は細胞内に送達するためのベクター | |
| JP6818264B2 (ja) | 高密度リポタンパク質およびその細胞親和性ペプチドを融合した高密度リポタンパク質の点眼による後眼部薬物デリバリー | |
| CN101646462A (zh) | 药物转运控制用经肺给药脂质体 | |
| Patel et al. | Liposome drug delivery system: a critic review | |
| US7001614B2 (en) | Liposome complexes for increased systemic delivery | |
| DE69528170T2 (de) | Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen | |
| JP3910646B2 (ja) | 「細胞への遺伝子導入用組成物」 | |
| JP2023545924A (ja) | 対象における生体分子を発現するためのシステム及び方法 | |
| EP1677763A1 (en) | Lipophilic drug delivery vehicle and methods of use thereof | |
| JP2001002592A (ja) | 遺伝子導入用組成物 | |
| Bhattacharya et al. | Virosomes: A novel strategy for drug delivery and targeting | |
| US20260077037A1 (en) | Cationic lipid based composition, formulation and use for nucleic acid vaccine delivery and preparation thereof | |
| JPWO2009060710A1 (ja) | リポソームに抗体結合能を付与するペプチド、および当該ペプチドで修飾されたリポソーム | |
| KR100996975B1 (ko) | 혈류 내 순환시간 증가를 위한 단백질로 수식된 리포솜 및이의 제조방법 |